Low-dose aspirin for the prevention of preeclampsia in women with polycystic ovary syndrome: a retrospective cohort study
Abstract Background The objective of this study was to investigate the efficacy of low-dose aspirin (LDA) in preventing preeclampsia among pregnant women with polycystic ovary syndrome (PCOS), given the increased susceptibility of this population to preeclampsia development. Methods A retrospective...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | BMC Pregnancy and Childbirth |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12884-025-07183-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832571279484387328 |
|---|---|
| author | Shouling Luo Xiaoyue Zhang Zhenzhen Liu Chengjie Wang Jiangnan Pei Yi Yu Haiyan Liu Weirong Gu |
| author_facet | Shouling Luo Xiaoyue Zhang Zhenzhen Liu Chengjie Wang Jiangnan Pei Yi Yu Haiyan Liu Weirong Gu |
| author_sort | Shouling Luo |
| collection | DOAJ |
| description | Abstract Background The objective of this study was to investigate the efficacy of low-dose aspirin (LDA) in preventing preeclampsia among pregnant women with polycystic ovary syndrome (PCOS), given the increased susceptibility of this population to preeclampsia development. Methods A retrospective cohort study was conducted on pregnant women with PCOS who delivered between January 1, 2018 and February 10, 2024 at our institution. Clinical characteristics and obstetric data were extracted from medical records. Propensity score matching (PSM) was employed to analyze the association between LDA use and PE incidence. Results The study cohort comprised 1522 pregnant women with PCOS. Among 395 pregnant women identified as high-risk for preeclampsia, 98 were administered LDA for preeclampsia prevention, while 297 did not receive LDA. Following PSM, no statistically significant difference was observed in preeclampsia risk between the LDA and non-LDA groups. Additionally, maternal and neonatal outcomes were comparable between the two groups. Conclusions This cohort analysis did not provide sufficient evidence to support the efficacy of LDA in preventing preeclampsia among PCOS patients at high risk for preeclampsia. |
| format | Article |
| id | doaj-art-ff1f41fd365540e48b92c607f941f675 |
| institution | Kabale University |
| issn | 1471-2393 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Pregnancy and Childbirth |
| spelling | doaj-art-ff1f41fd365540e48b92c607f941f6752025-02-02T12:46:55ZengBMCBMC Pregnancy and Childbirth1471-23932025-01-012511610.1186/s12884-025-07183-1Low-dose aspirin for the prevention of preeclampsia in women with polycystic ovary syndrome: a retrospective cohort studyShouling Luo0Xiaoyue Zhang1Zhenzhen Liu2Chengjie Wang3Jiangnan Pei4Yi Yu5Haiyan Liu6Weirong Gu7The Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan UniversityThe Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan UniversityThe Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan UniversityThe Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan UniversityThe Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan UniversityThe Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan UniversityThe Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan UniversityThe Department of Obstetrics, Obstetrics and Gynecology Hospital of Fudan UniversityAbstract Background The objective of this study was to investigate the efficacy of low-dose aspirin (LDA) in preventing preeclampsia among pregnant women with polycystic ovary syndrome (PCOS), given the increased susceptibility of this population to preeclampsia development. Methods A retrospective cohort study was conducted on pregnant women with PCOS who delivered between January 1, 2018 and February 10, 2024 at our institution. Clinical characteristics and obstetric data were extracted from medical records. Propensity score matching (PSM) was employed to analyze the association between LDA use and PE incidence. Results The study cohort comprised 1522 pregnant women with PCOS. Among 395 pregnant women identified as high-risk for preeclampsia, 98 were administered LDA for preeclampsia prevention, while 297 did not receive LDA. Following PSM, no statistically significant difference was observed in preeclampsia risk between the LDA and non-LDA groups. Additionally, maternal and neonatal outcomes were comparable between the two groups. Conclusions This cohort analysis did not provide sufficient evidence to support the efficacy of LDA in preventing preeclampsia among PCOS patients at high risk for preeclampsia.https://doi.org/10.1186/s12884-025-07183-1Low-dose aspirinPCOSPreeclampsiaPSMFGR |
| spellingShingle | Shouling Luo Xiaoyue Zhang Zhenzhen Liu Chengjie Wang Jiangnan Pei Yi Yu Haiyan Liu Weirong Gu Low-dose aspirin for the prevention of preeclampsia in women with polycystic ovary syndrome: a retrospective cohort study BMC Pregnancy and Childbirth Low-dose aspirin PCOS Preeclampsia PSM FGR |
| title | Low-dose aspirin for the prevention of preeclampsia in women with polycystic ovary syndrome: a retrospective cohort study |
| title_full | Low-dose aspirin for the prevention of preeclampsia in women with polycystic ovary syndrome: a retrospective cohort study |
| title_fullStr | Low-dose aspirin for the prevention of preeclampsia in women with polycystic ovary syndrome: a retrospective cohort study |
| title_full_unstemmed | Low-dose aspirin for the prevention of preeclampsia in women with polycystic ovary syndrome: a retrospective cohort study |
| title_short | Low-dose aspirin for the prevention of preeclampsia in women with polycystic ovary syndrome: a retrospective cohort study |
| title_sort | low dose aspirin for the prevention of preeclampsia in women with polycystic ovary syndrome a retrospective cohort study |
| topic | Low-dose aspirin PCOS Preeclampsia PSM FGR |
| url | https://doi.org/10.1186/s12884-025-07183-1 |
| work_keys_str_mv | AT shoulingluo lowdoseaspirinforthepreventionofpreeclampsiainwomenwithpolycysticovarysyndromearetrospectivecohortstudy AT xiaoyuezhang lowdoseaspirinforthepreventionofpreeclampsiainwomenwithpolycysticovarysyndromearetrospectivecohortstudy AT zhenzhenliu lowdoseaspirinforthepreventionofpreeclampsiainwomenwithpolycysticovarysyndromearetrospectivecohortstudy AT chengjiewang lowdoseaspirinforthepreventionofpreeclampsiainwomenwithpolycysticovarysyndromearetrospectivecohortstudy AT jiangnanpei lowdoseaspirinforthepreventionofpreeclampsiainwomenwithpolycysticovarysyndromearetrospectivecohortstudy AT yiyu lowdoseaspirinforthepreventionofpreeclampsiainwomenwithpolycysticovarysyndromearetrospectivecohortstudy AT haiyanliu lowdoseaspirinforthepreventionofpreeclampsiainwomenwithpolycysticovarysyndromearetrospectivecohortstudy AT weironggu lowdoseaspirinforthepreventionofpreeclampsiainwomenwithpolycysticovarysyndromearetrospectivecohortstudy |